Research Article
In Vivo Investigation of ALBO-OS Scaffold Based on Hydroxyapatite and PLGA
Table 6
Presence of neoangiogenesis, mineralization, and connective tissue in defects 12 weeks after implantation of ALBO-OS and Bio-Oss.
| | Parameter | Response | Percentage of defects | value
ALBO-OS/Bio-Oss | | ALBO-OS | Bio-Oss | Without |
| | Neoangiogenesis | No | 55 | 57.1 | — | 1.000 | | 1–3 bv/HPM | 35 | 28.6 | — | | 4–7 bv/HPM | 10 | 14.3 | — |
| | Mineralization | No | 0 | 0 | 20 | <0.001 | | <25% | 0 | 28.6 | 60 | | 25–50% | 0 | 57.1 | 20 | | 51–75% | 30 | 14.3 | 0 | | 76–100% | 70 | 0 | 0 |
| | Connective tissue | No | 75 | 0 | 0 | <0.001 | | 0–25% | 25 | 14.3 | 0 | | 26–50% | 0 | 28.6 | 30 | | 51–100% | 0 | 57.1 | 70 |
|
|
